GSK plans to invest over £200 million to improve its UK sites
The company’s new production facility in Montrose, Scotland, is slated for completion this year
British Pharma giant, GSK is planning to invest more than £200...
EMA recommends approving GSK’s oral therapy for rare blood cancer
A decision on EU marketing authorisation for oral therapy is expected by early 2024.
The Committee for Medicinal Products for Human Use (CHMP) of...
Inventor gifts tablet press to the University students
The equipment (Tablet Press Machine) can be used in pharmaceutical studies as well as metallurgy and 3D printing
Dr Michael Gamlen, the inventor of Gamlen...
Grundon launches maiden UK-wide inhaler recycling programme
Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and recycling initiative. NHS Trusts and community...
Haleon not surprised by Pfizer stake sale plans, says CFO
Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday (3 May).
London-listed...
GSK licenses Aurobindo, Cipla and Viatris to make generic versions of injectable cabotegravir
British drugmaker GSKÂ has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in...